Humana Inc. Files 8-K for Regulation FD Disclosure

TL;DR

Humana dropped an 8-K for a Reg FD disclosure - check for news.

AI Summary

On October 2, 2024, Humana Inc. filed an 8-K report. The filing primarily serves as a notification of a Regulation FD Disclosure, indicating that the company has made a public disclosure of material information. No specific financial transactions or material events beyond this disclosure are detailed in the provided excerpt.

Why It Matters

This filing signals that Humana Inc. has made a public disclosure of information, which is important for investors to stay informed about material company news.

Risk Assessment

Risk Level: low — The filing is a standard procedural disclosure and does not contain information about significant financial changes, legal issues, or operational disruptions.

Key Players & Entities

• Humana Inc. (company) — Registrant
• October 2, 2024 (date) — Date of Report
• 500 West Main Street Louisville, KY 40202 (address) — Principal executive offices
• 502 - 580-1000 (phone_number) — Registrant's telephone number

FAQ

Filing Documents

• hum-20241002.htm (8-K) — 29KB
• 0000049071-24-000045.txt ( ) — 150KB
• hum-20241002.xsd (EX-101.SCH) — 2KB
• hum-20241002_lab.xml (EX-101.LAB) — 21KB
• hum-20241002_pre.xml (EX-101.PRE) — 12KB
• hum-20241002_htm.xml (XML) — 3KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. Based on preliminary 2025 Medicare Advantage (MA) Star Ratings data provided by the Centers for Medicare and Medicaid Services (CMS), which became available in CMS Plan Finder as of October 1, 2024, Humana Inc. ("the Company") has approximately 1.6 million, or 25%, of its members currently enrolled in plans rated 4 stars and above for 2025, a reduction from 94% in 2024. A significant driver of these results was contract H5216 decreasing to a 3.5-star rating from a 4.5-star rating in 2024. H5216 contains approximately 45% of Humana's MA membership, including greater than 90% of its employer group waiver plan (Group MA) membership. The decline in Stars performance for 2025 will impact Humana's quality bonus payments in 2026. 2025 Star rating details are expected to be formally released by CMS on or around October 10 th . Based on the Company's review of the preliminary data provided by CMS, its reduction in Star ratings was driven by narrowly missing higher industry cut points on a small number of measures. Humana believes there may be potential errors in CMS' calculation of certain of its results and industry threshold cut points. The Company has outstanding appeals related to certain results and has requested additional information to ensure accuracy of threshold calculations. The Company intends to continue to engage with CMS on these matters to ensure Star ratings are accurate and representative of plan quality. Despite on-going appeal efforts, the Company is disappointed with its performance and has initiatives underway focused on improving its operating discipline and returning to an industry leading Stars position as quickly as possible. These initiatives are expected to impact performance across key measures and drive improved quality bonus payments in 2027 and beyond. Areas of focus include enhancing member and provider engagement strategies, improving customer experience and strengthening technology integrations to s

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. HUMANA INC. BY: /s/ John-Paul W. Felter John-Paul W. Felter Senior Vice President, Chief Accounting Officer & Controller (Principal Accounting Officer) Dated: October 2, 2024

View Full Filing

View this 8-K filing on SEC EDGAR